Back

The P2X7 receptor is an intermediate in the retinoic acid-signaling pathway that induces neuronal remodeling in retinitis pigmentosa

Telias, M.; Afrima, L.; Endres, J. W.; Denlinger, B.; Kramer, R. H.

2026-05-31 neuroscience
10.64898/2026.05.27.728267 bioRxiv
Show abstract

Photoreceptor degeneration drives electrophysiological remodeling in downstream retinal neurons, including hyperactive firing of retinal ganglion cells (RGCs) that degrades residual vision. Although Retinoic Acid (RA) and its receptor (RAR) are known to upregulate ion channel genes associated with RGC hyperactivity, these genes lack canonical RAR binding sites required for direct transcriptional regulation. Here, we identify P2X7 receptor (P2X7R) as a key intermediary in RA-induced remodeling in the rd1 mouse model of retinitis pigmentosa. Genetic deletion of P2X7R prevents the upregulation of RA-responsive genes and abolishes RGC hyperactivity. Loss of P2X7R also eliminates RGC hyperpermeability, as measured by uptake of an otherwise membrane-impermeant dye. Acute pharmacological inhibition of P2X7R suppresses hyperpermeability without affecting hyperactivity, supporting an indirect signaling mechanism rather than a direct electrophysiological role. Notably, elevation of resting Ca{superscript 2} is absent in P2X7R-deficient cells, implicating Ca{superscript 2}-dependent gene expression as a link between P2X7R-mediated hyperpermeability and RGC hyperactivity. Together, these findings establish P2X7R as a critical intermediate in retinal remodeling and a potential therapeutic target for preserving vision in retinitis pigmentosa. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=122 SRC="FIGDIR/small/728267v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@7745d4org.highwire.dtl.DTLVardef@89a01corg.highwire.dtl.DTLVardef@16ea51borg.highwire.dtl.DTLVardef@119d0f9_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 0.3%
23.1%
2
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 11%
6.5%
3
Cell Reports
1338 papers in training set
Top 7%
6.5%
4
PLOS Genetics
756 papers in training set
Top 4%
4.1%
5
JCI Insight
241 papers in training set
Top 1%
4.1%
6
Cell Death & Disease
126 papers in training set
Top 0.3%
3.7%
7
Developmental Cell
168 papers in training set
Top 5%
3.7%
50% of probability mass above
8
Nature Communications
4913 papers in training set
Top 45%
2.7%
9
The Journal of Neuroscience
928 papers in training set
Top 4%
2.4%
10
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.3%
1.9%
11
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.4%
1.8%
12
eneuro
389 papers in training set
Top 5%
1.7%
13
Journal of Biological Chemistry
641 papers in training set
Top 2%
1.7%
14
Human Molecular Genetics
130 papers in training set
Top 2%
1.7%
15
Experimental Neurology
57 papers in training set
Top 0.7%
1.5%
16
Science Advances
1098 papers in training set
Top 21%
1.4%
17
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.3%
18
Scientific Reports
3102 papers in training set
Top 65%
1.3%
19
Neurobiology of Disease
134 papers in training set
Top 3%
1.1%
20
Science Signaling
55 papers in training set
Top 0.3%
1.0%
21
EMBO reports
136 papers in training set
Top 5%
0.9%
22
iScience
1063 papers in training set
Top 25%
0.9%
23
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
24
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
25
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
26
PLOS Biology
408 papers in training set
Top 20%
0.7%
27
The FASEB Journal
175 papers in training set
Top 4%
0.7%
28
Neuron
282 papers in training set
Top 9%
0.7%
29
Frontiers in Neurology
91 papers in training set
Top 6%
0.7%
30
Development
440 papers in training set
Top 4%
0.5%